Clinical Trials

FDA Comments — Office of Women’s Health Strategic Priorities

By Sarah Christopherson | Sep 8, 2020 | Comments Off on FDA Comments — Office of Women’s Health Strategic Priorities

Public comments urging the FDA’s Office of Women’s Health to ensure that women’s needs are represented across FDA and in the agency’s research, education, and public outreach.

Taking on Gender Bias in Clinical Trials

By NWHN Staff | Feb 26, 2019 | Comments Off on Taking on Gender Bias in Clinical Trials

We have made progress as a country, but there is still work to be done. Clinical trials need to broaden their subject base and do a better job of representing all affected parties for the sake of equality and the generation of more rational, insightful data. Patients and healthcare professionals need great transparency and “accurate information about the medical products available to them.”

FDA Approvals: On a Fast-Track to Disaster

By Caila Brander | Sep 14, 2017 | Comments Off on FDA Approvals: On a Fast-Track to Disaster

Most of us want to be confident when we start a newly prescribed treatment that the medication we take will improve the ailment we seek to treat. We believe that our drugs have been tested and proven effective. We assume that the U.S. Food and Drug Administration (FDA) verifies that any drug that hits the market is safe…

FDA Meeting – Clinical Trial Diversity

By Sarah Christopherson | Feb 29, 2016 | Comments Off on FDA Meeting – Clinical Trial Diversity

Food and Drug Administration Safety and Innovation Act 907 Public Meeting: Progress on Enhancing the Collection, Analysis, and Availability of Demographic Subgroup Data

Clinical Trials: Greater Inclusion of Women

By NWHN Staff | Aug 14, 2015 | Comments Off on Clinical Trials: Greater Inclusion of Women

The NWHN advocates for the greater participation of women and other key groups in clinical trials for all drugs and devices, and particularly for products that are principally marketed and used by women.

Join Me on a Webinar

By Cindy Pearson | Aug 13, 2015 | Comments Off on Join Me on a Webinar

When done well, clinical trials can help answer research questions and provide access to cutting edge treatments. They establish standards of care and inform the Food and Drug Administration (FDA) drug approval process. Once a treatment is FDA approved, it…

Patient Safety Over Politics

By NWHN Staff | Jul 16, 2015 | Comments Off on Patient Safety Over Politics

In Washington, it can be hard to find an issue that politicians agree on across party lines. Last week, the U.S. House of Representatives passed the 21st Century Cures Act (H.R. 6) in a 344-77 vote, and now the bill heads to the Senate.

Mammography

By NWHN Staff | Jul 9, 2015 | Comments Off on Mammography

Mammography uses X-rays to take images of the breasts and identify cancer when it’s too small to be felt so it can be treated early and aggressively.